SINGAPORE - Media OutReach - 19 May 2021 - As Singapore continues to roll out its COVID-19 vaccination programme in its steady efforts to contain the virus with hopes of gradual return to normalcy, Etiqa Insurance Pte. Ltd. ("Etiqa Insurance Singapore") extends its Financial Assistance Benefit for side effects of COVID-19 vaccine to all existing and new individual customers of Maybank Singapore. Application is not required and coverage is free of charge.
Maybank Singapore Limited's consumer banking customers will receive a Hospitalisation Benefit of up to S$1,000 over a maximum of 10 days, and an Intensive Care Unit Benefit of up to S$1,000 over a maximum of 5 days if they experience any COVID-19 vaccination side effects.
The existing COVID-19 Financial Assistance Benefit and vaccination side effects coverage currently protect Etiqa's eligible customers1 against the virus and any unexpected effects from vaccinations of any COVID-19 vaccine which is approved for use in Singapore by the Health Sciences Authority (HSA) and administered in Singapore.
The complimentary coverage is now extended to Maybank customers with an individual account in Singapore. New customers are defined as those who are holding account(s) with Maybank Singapore Limited for at least three months.
Mr Raymond Ong, Chief Executive Officer of Etiqa Insurance Singapore said, "The health and well-being of our people and customers remain a priority for us. To support the progressive reopening of Singapore and everyone to vaccinate with confidence, we hope that this added layer of protection provides assurance and greater peace of mind for customers of both Etiqa and Maybank Singapore while they take active steps to protect themselves and their loved ones."
Dr John Lee, Country CEO and CEO of Maybank Singapore adds, "We stand in solidarity with our customers and support the vaccination programme rolled out by the Singapore Government. The impact of Covid-19 pandemic is long lasting and we strive to protect the well-being of our customers by providing them with Etiqa's complimentary Financial Assistance Benefit. This move is one of the ways we humanise financial services to care for our customers. Since last year, we have also provided deferred loan repayment scheme to help ease customers' financial burden."
For more information, please visit www.etiqa.com.sg/covid19-relief.
1 The COVID-19 Financial Assistance Benefit is eligible to all existing and new Insured Person(s) of life protection and insurance savings plans underwritten by Etiqa Insurance Pte. Ltd.. For full terms and conditions, please visit www.etiqa.com.sg/financial-assistance-benefit-life.
The Financial Assistance Benefit for side effects of COVID-19 Vaccine is eligible to all existing and new individual customers of Maybank Singapore Limited, all existing and new Life assured of life protection and insurance savings plans and all existing and new Insured of selected personal lines insurance policies underwritten by Etiqa Insurance Pte. Ltd. For full terms and conditions, please visit www.etiqa.com.sg/covid19-updates/vaccine-benefits/.
Terms and conditions apply. Protected up to specified limits by SDIC. Etiqa Singapore reserves the discretion to make amendments to the benefits and its validity at any time.
- Etiqa Launches AMBER – A Holistic Retirement Ecosystem That Supports Customers with Their Physical, Mental and Financial Health for Better Quality of Life
- AXA launches "Free Double Post-Vaccination Protection" Programme
- Five people suffer from Covid-19 vaccine side effects
- Five people experience side effects after COVID-19 vaccination
- 33% of Covid-19 vaccine recipients suffer from slight allergic reactions
- Danang suspends Covid-19 vaccination after vaccinated nurse encounters anaphylaxis
- DirectAsia Reveals 5 Factors That Could Influence Your Car Insurance Quotes in Singapore
- Blue Cross launches brand-new LovePet Outpatient Insurance
- AXA extends holistic wellness platform "AXA BetterMe" to all Employee Benefits customers Leveraging technology and thoughtful services to raise competitiveness of corporates